[Oncogenesis by herpesvirus].
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D000961:Antilymphocyte Serum; D002051:Burkitt Lymphoma / Q000382:microbiology; D002478:Cells, Cultured; D004279:DNA, Viral; D005260:Female; D006367:HeLa Cells / Q000382:microbiology; D006564:Herpesviridae / Q000472:pathogenicity*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D006824:Hybridization, Genetic; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008854:Microscopy, Electron; D009369:Neoplasms / Q000382:microbiology*; D009858:Oncogenic Viruses; D018139:Simplexvirus / Q000145:classification / Q000302:isolation & purification; D014183:Transplantation, Heterologous; D002583:Uterine Cervical Neoplasms / Q000382:microbiology; D014779:Virus Replication
D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D004279:DNA, Viral
Oncogenesi da herpesvirus.